Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Guangzhou City, China Clinical Trials

A listing of Guangzhou City, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (10) clinical trials

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

This study will evaluate the safety, tolerability, pharmacokinetic and efficacy of fisogatinib (formerly known as BLU-554) in combination with CS1001 in patients with locally advanced or metastatic hepatocellular carcinoma (HCC)

Phase

0.0 miles

Learn More »

Effectiveness of Regenerative Endodontics Therapy for Single-rooted Mature Permanent Tooth With Pulp Necrosis

Regenerative endodontics therapy (RET), based on the principles of tissue engineering, manipulates stem cells, scaffold, and bioactive growth factors to achieve the functional reconstruction of pulp tissue. RET has been recommended strongly as an alternative in treating immature permanent teeth with necrotic pulp in recent years, while root canal therapy ...

Phase N/A

0.0 miles

Learn More »

Programmed Death-1 (PD-1) Antibody Combined With IMRT in Recurrent Nasopharyngeal Carcinoma Patients

This is a multicenter, randomized controlled, phase III clinical trial. The purpose of this study is to evaluate the efficacy and adverse effect of PD-1 antibody with IMRT versus IMRT alone in recurrent nasopharyngeal carcinoma patients.

Phase

0.0 miles

Learn More »

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

Acquired immune deficiency syndrome(AIDS) is a severe fatal disease caused by HIV infection. Despite viral suppression achieved, antiretroviral therapy(ART) cannot ameliorate HIV-induced immune activation and the consequent non-AIDS complications including cardiovascular, renal, hepatic diseases. Recently, immunosuppression therapy has become the focus since it can suppress exorbitant immune activation and inflammation ...

Phase

1.58 miles

Learn More »

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

This is a a prospective, single-arm phase II clinical trial. The purpose of this study is to evaluate the efficacy and adverse effect of PD-1 antibody with chemotherapy in high-risk recurrent nasopharyngeal carcinoma.

Phase

1.58 miles

Learn More »

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage

Esophageal cancer (EC) is the most common cancers in the world, with more than 16,910 new cases and 15,690 deaths annually worldwide. Every year in China, no matter new cases or deaths account for more than half of the world. Currently, surgery is the most important and effective treatment for ...

Phase

1.58 miles

Learn More »

Anlotinib Hydrochloride for Soft Tissue Sarcoma Patients.

This regional multi-center study is planned to be carried out in Guangdong and Sichuan provinces. 48 cases are preliminarily expected to be included. The study will start in January 2019 and end in December 2019. It is expected that the trial will end in December 2020. This study evaluating the ...

Phase

1.58 miles

Learn More »

UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma

Efficacy: 1. Main objective: (1)Assess the decrease in postoperative intraocular pressure from baseline and evaluate the final results (the percentage of patients whose conditions have significant improved and the variation of the percentage of median intraocular pressure. (2)Assess the amount of medication after surgery. Secondary goals:(1) Compare median intraocular pressure ...

Phase N/A

1.58 miles

Learn More »

Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus

TQ-F3083 capsule is a new type inhibitor of DPP-IV, which is currently a very effective target for the treatment of type 2 diabetes mellitus at clinical. In addition, it can promote insulin secretion with low potential toxicity, and half-life is shorter than Linagliptin.

Phase

5.03 miles

Learn More »

Toripalimab in Combination With R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

This study will research untreated elderly diffuse large B cell lymphoma patients respond and safty to toripalimab combined with R-CHOP chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) therapy.

Phase

6.22 miles

Learn More »